Rachel Redfern received her bachelor's degree in biology from Texas A&M University and then her OD/PhD from the University of Houston, College of Optometry. In 2006, Dr. Redfern received the Institutional Ruth Kirschstein National Research Post-doctorate Award and the ARVO/Alcon Early Career Clinician-Scientist Research Award. Dr. Redfern is a member of the Association for Research in Vision and Ophthalmology, the American Academy of Optometry and the Tear Film and Ocular Surface Society. She is also a past William C. Ezell Fellow.

Her laboratory is interested in ocular surface inflammation/infection, the impact of contact lenses (e.g. scleral gas permeable lenses) on normal and diseased eyes and the functional and anatomical changes that occurs in the meibomian glands with age and disease. They perform human subject, animal and in vitro studies. Dr. Redfern’s laboratory is NIH funded to examine the impact of toll-like receptors on the production of damaging cytokines and matrix metalloproteases and beneficial antimicrobial peptides on the ocular surface.